Approval · Notice of Compliance 3299 · 1997
ZITHROMAX: Notice of Compliance 3299
Issued April 17, 1997
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3299
- Date
- April 17, 1997
- Company
- Pfizer Canada UlcKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New indication: prevention of disseminated mac disease and a new strength
- Therapeutic class
- Antibiotic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ZITHROMAX | 02231143 | Cancelled Post Market |
Medicinal ingredients
- AZITHROMYCIN 600 MG per TAB